The most important Medicare changes are the ones that affect what you pay, which doctors you can see, and how you get your prescriptions. Looking ahead to 2027, several changes are already confirmed, including higher Part D spending limits, another round of negotiated drug prices, and the end of a temporary program that helped stabilize certain prescription drug plan premiums.
Other details require a closer look at your individual coverage. Medicare Advantage and prescription drug plans can change their costs and coverage from one year to the next. Keeping the same plan does not necessarily mean keeping the same benefits.
Here are the major developments to watch, along with practical examples of how to prepare.
1. The Medicare Part D Spending Limit Is Increasing
Starting January 1, 2027, the annual out-of-pocket limit for covered Medicare Part D prescriptions will increase to $2,400, up from $2,100 in 2026. The maximum standard Part D deductible will also increase, from $615 to $700. Individual plans may have a lower deductible or no deductible.
Once your qualifying spending reaches the annual limit, you will owe no additional copayments or coinsurance for covered Part D drugs for the rest of the calendar year. Your deductible counts toward that limit. It is not an additional $700 on top of $2,400. Premiums and prescriptions your plan does not cover are outside this protection, and the Part D limit does not apply to drugs covered under Part B.
For example, someone who reaches the spending limit in both years, without financial assistance, should budget for up to $300 more in covered prescription expenses in 2027. Someone who takes only inexpensive medications may never reach either year’s limit.
Watch your plan’s deductible, drug coverage and pharmacy pricing rather than assuming the annual cap represents what everyone will pay.
The Medicare Prescription Payment Plan remains another budgeting option. It allows participating beneficiaries to spread their covered out-of-pocket prescription costs over the remaining months of the calendar year. It changes when you pay, not the total amount you owe.
2. Negotiated Prices Are Expanding to More Prescription Drugs
Negotiated Medicare prices for another 15 selected Part D drugs will take effect on January 1, 2027. The group includes medications such as Trelegy Ellipta, Linzess, and the selected drug grouping that includes Ozempic, Rybelsus and Wegovy.
This is an important development, but a negotiated drug price is not necessarily your pharmacy copayment. What you pay still depends on your plan’s benefit structure, your coverage stage and other applicable coverage rules. A lower underlying price will not affect every enrollee’s costs in exactly the same way.
For example, someone taking Trelegy Ellipta should compare their plan’s estimated annual cost for the correct medication and dosage. They should not assume that a published negotiated price is the amount they will personally pay each month.
The next expansion is also worth watching. Medicare selected another 15 drugs for negotiations leading to prices effective in 2028, including drugs payable under Part B for the first time. That extends the program’s reach beyond medications typically obtained through Part D coverage.
3. Prescription Drug Plan Premiums Need a Fresh Review
CMS has announced that the temporary Part D Premium Stabilization Demonstration will end after 2026. This program helped stabilize premiums for participating stand-alone prescription drug plans during the transition to the redesigned Part D benefit. Its expiration makes reviewing your actual 2027 premium particularly important.
A separate rule limits annual increases in the national Part D base beneficiary premium to 6% through 2029. That is not a 6% limit on the premium increase for every individual plan. The base beneficiary premium is part of the formula used to calculate plan premiums, not a universal price paid by everyone.
For example, a hypothetical $15 monthly premium increase would add $180 to your annual expenses, even if your prescription copayments stayed the same.
Compare the full-year combination of premiums, deductibles and prescription costs. A plan with a lower monthly premium is not automatically the less expensive choice for your particular medications.
4. Medicare Advantage Benefits and Networks May Change
Medicare Advantage plans can change their costs and coverage rules each year. When reviewing 2027 coverage, look beyond the premium and check specialist copayments, hospital costs, the medical out-of-pocket maximum, prescription coverage and provider participation. A $0 plan premium does not eliminate your other Medicare expenses.
There are also confirmed changes involving certain supplemental benefits. For 2027, CMS is requiring plans to publicly post their eligibility criteria for Special Supplemental Benefits for the Chronically Ill. The final rule also clarifies that benefit debit cards must be linked to eligible covered purchases and limited to the applicable plan year.
For example, an advertisement for a benefit card does not establish that you qualify for every advertised benefit. Before including an allowance in your household budget, ask which eligibility requirements apply, what purchases are permitted and when the benefit expires.
Separately, confirm your doctors and hospitals with both the plan and the providers. Do not assume that a familiar insurer’s name means every plan from that company uses the same network.
Also watch for a non-renewal notice. A notice that your plan is leaving Medicare is different from an ordinary annual benefits update and may require you to arrange replacement coverage.
5. Prior Authorization Is Becoming More Electronic
For Medicare Advantage, an important 2027 development involves electronic systems for prior authorization, which is approval a plan may require before certain care is provided. CMS rules require affected insurers to implement electronic tools beginning January 1, 2027, to communicate requirements, accept requests and return decisions for medical items and services covered by the rule. These requirements exclude drug authorizations.
Related process requirements began in 2026. They generally require decisions within seven calendar days for standard requests and 72 hours for expedited requests, subject to applicable rules and permitted extensions. Plans must also provide a specific reason for denying a request.
For example, when your doctor requests authorization for an imaging test, ask when the plan received the request, whether it is being treated as standard or urgent, and whether more information is needed.
Electronic processing may reduce unnecessary back-and-forth, but it does not guarantee approval. These changes improve the process; they do not eliminate prior authorization.
6. Broad Telehealth Access Continues Through 2027
Medicare’s broad telehealth flexibilities have been extended through December 31, 2027. During this period, beneficiaries can receive covered telehealth services from home and other locations throughout the United States, rather than generally having to visit a rural medical facility. Coverage requirements still apply to the particular service.
The key future date to watch is January 1, 2028. Under current rules, many location and practitioner restrictions are scheduled to return unless the law changes again. Some services, including certain behavioral health services, have separate exceptions.
For example, someone who relies on virtual follow-up visits should ask whether their specific appointments qualify for Medicare coverage in 2027 and monitor the rules before scheduling care in 2028.
A virtual visit is not automatically free. In Original Medicare, covered telehealth generally remains subject to the Part B deductible and 20% coinsurance.
7. Access to Certain Weight-Loss Drugs Is Expanding, but Not for Everyone
The Medicare GLP-1 Bridge launched on July 1, 2026, and is scheduled to remain available through December 31, 2027. It gives eligible people enrolled in qualifying Medicare Part D coverage access to certain GLP-1 medications for weight management at $50 per month. This is a temporary demonstration, not universal coverage for every weight-loss drug or every Medicare beneficiary.
Eligibility depends on specific clinical and coverage requirements. People who are already eligible to receive a GLP-1 medication through their ordinary Part D benefit generally must use that coverage instead. Bridge payments do not count toward the Part D deductible or annual out-of-pocket limit, and these drugs are not eligible for the Medicare Prescription Payment Plan when obtained through the demonstration.
For example, someone considering medication for weight management should ask their doctor whether they meet the Bridge’s requirements and whether the prescribed product qualifies. They should not assume that every formulation of a brand-name medication is included.
For longer-term planning, distinguish the program’s confirmed availability through 2027 from any future expansion that has not been finalized.
8. Part A and Part B Costs Still Need a Separate Budget Check
Do not confuse finalized 2027 Part D limits with finalized costs for every part of Medicare. As of this article’s update, Medicare’s official cost page still lists 2026 Part A and Part B amounts. Check the official 2027 announcements for premiums, deductibles and other cost-sharing amounts rather than relying on projections presented as confirmed rates.
For reference, the standard Part B premium is $202.90 per month in 2026, and the annual Part B deductible is $283. Those are 2026 figures, not confirmed 2027 rates.
Income also matters. Social Security generally uses tax information from two years earlier when determining income-related premium surcharges for Parts B and D. This is an existing rule that remains important when planning ahead.
For example, a large taxable gain in 2026 could affect Medicare premiums in 2028. Conversely, someone whose income falls because of retirement or another qualifying life-changing event may be able to request a new surcharge determination from Social Security.
How to Prepare for Medicare Open Enrollment
Start with your Annual Notice of Change, which your Medicare Advantage or drug plan sends in September. It explains changes taking effect in January. Contact the plan if you do not receive it.
Then compare your coverage using your current prescriptions, dosages and preferred pharmacies. Confirm the doctors and hospitals you use, and review both expected annual expenses and your exposure to a more expensive year of medical care. Medicare’s plan comparison tools can help estimate costs, and State Health Insurance Assistance Programs offer free, unbiased counseling.
Medicare Open Enrollment runs from October 15 through December 7, 2026, for coverage effective January 1, 2027. During this period, eligible beneficiaries can change Medicare Advantage or Part D coverage or switch between Original Medicare and Medicare Advantage.
One caution deserves special attention: this annual enrollment period does not create a universal right to buy Medigap without medical underwriting. Before leaving Medicare Advantage with the expectation of buying supplemental coverage, check whether you have guaranteed-issue rights or additional protections under state law.
The most useful question is not simply, “Is my plan still available?” It is, “Will this coverage still work for my doctors, prescriptions and budget next year?” Use the answers to guide your decision.
This article provides general educational information. Coverage, eligibility and costs depend on your circumstances and the terms of your plan.